Skip header and navigation

Refine By

   MORE

9 records – page 1 of 1.

[Classification of gastro-entero-pancreatic neuroendocrine tumors].

https://arctichealth.org/en/permalink/ahliterature152578
Source
Radiologe. 2009 Mar;49(3):198-205
Publication Type
Article
Date
Mar-2009
Author
A. Perren
A. Schmitt
P. Komminoth
M. Pavel
Author Affiliation
Institut für Pathologie und pathologische Anatomie, Klinikum rechts der Isar, Technische Universität München, München, Deutschland. aurel.perren@lrz.tum.de
Source
Radiologe. 2009 Mar;49(3):198-205
Date
Mar-2009
Language
German
Publication Type
Article
Keywords
Cell Transformation, Neoplastic - pathology
Diagnostic Imaging
Digestive System Neoplasms - classification - diagnosis - pathology
Disease Progression
Humans
Neoplasm Invasiveness
Neoplasm Staging
Neuroendocrine Tumors - classification - diagnosis - pathology
Prognosis
Terminology as Topic
Abstract
Tumors of the disseminated/diffuse neuroendocrine system (NET) are characterized by a common phenotype. However, the biology varies according to histomorphology, endocrine symptoms and organ of origin. The WHO classification takes these differences into account and uses a common framework, where the parameters size and extent of invasion vary according to the organ of origin. In order to achieve a further standardization of reporting the European Neuroendocrine Tumor Society (ENETS) recently proposed a tumor-node-metastasis (TNM) staging and grading system for gastro-entero-pancreatic NET.
PubMed ID
19224191 View in PubMed
Less detail

ENETS Consensus Guidelines Update for Neuroendocrine Neoplasm of the Jejunum and Ileum.

https://arctichealth.org/en/permalink/ahliterature269172
Source
Neuroendocrinology. 2016 Jan 12;
Publication Type
Article
Date
Jan-12-2016

[Neuroendocrine neoplasms of the distal jejunum and ileum].

https://arctichealth.org/en/permalink/ahliterature259675
Source
Pathologe. 2014 May;35(3):283-93; quiz 294
Publication Type
Article
Date
May-2014
Author
M. Anlauf
B. Sipos
I. Boeck
S E Baldus
S. Heikaus
M. Krausch
W T Knoefel
N. Begum
P. Goretzki
M. Schott
C J Auernhammer
B. Cremer
A. Rinke
S. Ezziddin
C. Fottner
G. Pöpperl
H. Lahner
D. Hörsch
H E Gabbert
P. Komminoth
A. Perren
G. Klöppel
B. Wiedenmann
M. Pavel
U. Pape
Source
Pathologe. 2014 May;35(3):283-93; quiz 294
Date
May-2014
Language
German
Publication Type
Article
Keywords
Cell Proliferation
Diagnosis, Differential
Disease Progression
Enterochromaffin Cells - pathology
Humans
Ileal Neoplasms - pathology - surgery
Ileum - pathology - surgery
Jejunal Neoplasms - pathology - surgery
Jejunum - pathology - surgery
Neuroendocrine Tumors - pathology - surgery
Practice Guidelines as Topic
Receptors, Somatostatin - analysis
Abstract
Neuroendocrine neoplasms (NEN) of the distal jejunum and ileum derive from serotonin-producing enterochromaffin (EC) cells. Due to their low proliferation rate and their infiltrative growth, they are often discovered at an advanced disease stage when metastasis has already occurred. The biology of these tumours is different from other NEN of the digestive tract. In order to standardise and improve diagnosis and therapy, the guidelines for the diagnosis and clinical management of jejuno-ileal NEN as well as for the management of patients with liver and other distant metastases from NEN were revised by the European Neuroendocrine Tumour Society (ENETS) in 2012. This review focuses on aspects relevant for surgical pathology.
PubMed ID
24671468 View in PubMed
Less detail

[The ENETS and UICC TNM classification of neuroendocrine tumors of the gastrointestinal tract and the pancreas: comment].

https://arctichealth.org/en/permalink/ahliterature141104
Source
Pathologe. 2010 Sep;31(5):353-4
Publication Type
Article
Date
Sep-2010
Author
G. Klöppel
G. Rindi
A. Perren
P. Komminoth
D S Klimstra
Author Affiliation
Konsultationszentrum für Pankreas und Endokrine Tumoren, Institut für Pathologie, Technische Universität München, Ismaningerstr. 22, 81675, München, Deutschland. guenter.kloeppel@alumni.uni-kiel.de
Source
Pathologe. 2010 Sep;31(5):353-4
Date
Sep-2010
Language
German
Publication Type
Article
Keywords
Carcinoid Tumor - classification - pathology
Consensus
Gastrointestinal Neoplasms - classification - pathology
Humans
Neoplasm Invasiveness - pathology
Neoplasm Staging - methods
Neuroendocrine Tumors - classification - pathology
Pancreatic Neoplasms - classification - pathology
Prognosis
Societies, Medical
Notes
Comment On: Pathologe. 2010 Sep;31(5):348-5220798945
PubMed ID
20809402 View in PubMed
Less detail

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

https://arctichealth.org/en/permalink/ahliterature167548
Source
Virchows Arch. 2006 Oct;449(4):395-401
Publication Type
Conference/Meeting Material
Article
Date
Oct-2006
Author
G. Rindi
G. Klöppel
H. Alhman
M. Caplin
A. Couvelard
W W de Herder
B. Erikssson
A. Falchetti
M. Falconi
P. Komminoth
M. Körner
J M Lopes
A-M McNicol
O. Nilsson
A. Perren
A. Scarpa
J-Y Scoazec
B. Wiedenmann
Author Affiliation
Dipartimento di Patologia e, Medicina di Laboratorio, Sezione di Anatomia Patologica, Università di Parma, Via Gramsci, 14, 43100, Parma, Italy, and Department of Internal Medicine, Royal Free Hospital, London, UK. guido.rindi@unipr.it
Source
Virchows Arch. 2006 Oct;449(4):395-401
Date
Oct-2006
Language
English
Publication Type
Conference/Meeting Material
Article
Keywords
Digestive System Neoplasms - chemistry - classification - diagnosis
Humans
Lymph Nodes - chemistry - pathology
Mitotic Index
Neoplasm Metastasis - diagnosis
Neoplasm Staging - methods - standards
Neuroendocrine Tumors - chemistry - classification - diagnosis
Tumor Markers, Biological - analysis
Abstract
The need for standards in the management of patients with endocrine tumors of the digestive system prompted the European Neuroendocrine Tumor Society (ENETS) to organize a first Consensus Conference, which was held in Frascati (Rome) and was based on the recently published ENETS guidelines on the diagnosis and treatment of digestive neuroendocrine tumors (NET). Here, we report the tumor-node-metastasis proposal for foregut NETs of the stomach, duodenum, and pancreas that was designed, discussed, and consensually approved at this conference. In addition, we report the proposal for a working formulation for the grading of digestive NETs based on mitotic count and Ki-67 index. This proposal, which needs to be validated, is meant to help clinicians in the stratification, treatment, and follow-up of patients.
Notes
Cites: Digestion. 2000;62 Suppl 1:19-2610940683
Cites: Ann Oncol. 2006 Mar;17(3):461-616364959
Cites: Cancer. 2001 Oct 15;92(8):2204-1011596039
Cites: Int J Cancer. 2001 Nov 1;94(3):444-811745428
Cites: J Clin Oncol. 2002 Jun 1;20(11):2633-4212039924
Cites: Hum Pathol. 2002 Nov;33(11):1126-3212454818
Cites: Cancer. 2003 Feb 15;97(4):934-5912569593
Cites: Ann Oncol. 2004 Jun;15(6):966-7315151956
Cites: Ann Surg. 2004 Jul;240(1):117-2215213627
Cites: Digestion. 1988;41(4):185-2003072229
Cites: Hum Pathol. 1996 Nov;27(11):1124-348912819
Cites: J Clin Oncol. 1998 Mar;16(3):1040-539508189
Cites: Am J Gastroenterol. 1998 Mar;93(3):422-89517651
Cites: Gastroenterology. 1999 Mar;116(3):532-4210029611
Cites: Acta Oncol. 2004;43(7):617-2515545182
Cites: Acta Oncol. 2004;43(7):626-3615545183
Cites: Neuroendocrinology. 2004;80(4):244-5115627802
Cites: Am J Surg Pathol. 2005 Apr;29(4):524-3315767809
Cites: Gastroenterology. 2005 May;128(5):1187-9815887103
Cites: Gastroenterology. 2005 May;128(6):1717-5115887161
Cites: Gut. 2005 Jun;54 Suppl 4:iv1-1615888809
Cites: Neuroendocrinology. 2004;80(6):394-42415838182
Cites: Ann Oncol. 2005 Aug;16(8):1374-8015939719
Cites: Endocr Relat Cancer. 2005 Dec;12(4):1083-9216322345
Cites: Anticancer Res. 2005 Nov-Dec;25(6C):4463-916334127
Cites: Cancer Res. 2001 Jan 1;61(1):285-9211196176
PubMed ID
16967267 View in PubMed
Less detail

TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system.

https://arctichealth.org/en/permalink/ahliterature162101
Source
Virchows Arch. 2007 Oct;451(4):757-62
Publication Type
Conference/Meeting Material
Article
Date
Oct-2007
Author
G. Rindi
G. Klöppel
A. Couvelard
P. Komminoth
M. Körner
J M Lopes
A-M McNicol
O. Nilsson
A. Perren
A. Scarpa
J-Y Scoazec
B. Wiedenmann
Author Affiliation
Department of Pathology, University of Parma, Parma, Italy. guido.rindi@unipr.it
Source
Virchows Arch. 2007 Oct;451(4):757-62
Date
Oct-2007
Language
English
Publication Type
Conference/Meeting Material
Article
Keywords
Appendiceal Neoplasms - diagnosis - pathology
Carcinoma, Neuroendocrine - diagnosis - pathology
Cell Proliferation
Colonic Neoplasms - diagnosis - pathology
Europe
Guidelines as Topic
Humans
Ileal Neoplasms - diagnosis - pathology
Lymph Nodes - pathology
Lymphatic Metastasis
Neoplasm Staging - methods
Rectal Neoplasms - diagnosis - pathology
Abstract
Criteria for the staging and grading of neuroendocrine tumors (NETs) of midgut and hindgut origin were established at the second Consensus Conference in Frascati (Rome) organized by the European Neuroendocrine Tumor Society (ENETS). The proposed tumor-node-metastasis (TNM) classifications are based on the recently published ENETS Guidelines for the Diagnosis and Treatment of gastroenteropancreatic NETs and follow our previous proposal for foregut tumors. The new TNM classifications for NETs of the ileum, appendix, colon, and rectum, and the grading system were designed, discussed, and consensually approved by all conference participants. These proposals need to be validated and are meant to help clinicians in the stratification, treatment and follow-up of patients.
PubMed ID
17674042 View in PubMed
Less detail

TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.

https://arctichealth.org/en/permalink/ahliterature125020
Source
J Natl Cancer Inst. 2012 May 16;104(10):764-77
Publication Type
Article
Date
May-16-2012
Author
G. Rindi
M. Falconi
C. Klersy
L. Albarello
L. Boninsegna
M W Buchler
C. Capella
M. Caplin
A. Couvelard
C. Doglioni
G. Delle Fave
L. Fischer
G. Fusai
W W de Herder
H. Jann
P. Komminoth
R R de Krijger
S. La Rosa
T V Luong
U. Pape
A. Perren
P. Ruszniewski
A. Scarpa
A. Schmitt
E. Solcia
B. Wiedenmann
Author Affiliation
Institute of Anatomic Pathology, Università Cattolica del Sacro Cuore, Histopathology and Cytodiagnosis Unit, Policlinico Gemelli, Largo A. Gemelli, 8, Roma I-00168, Italy. guido.rindi@rm.unicatt.it
Source
J Natl Cancer Inst. 2012 May 16;104(10):764-77
Date
May-16-2012
Language
English
Publication Type
Article
Keywords
Adult
Age Distribution
Aged
Cohort Studies
Confounding Factors (Epidemiology)
Europe - epidemiology
Female
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Multivariate Analysis
Neoplasm Staging
Neuroendocrine Tumors - epidemiology - mortality - pathology
Observer Variation
Odds Ratio
Pancreatic Neoplasms - epidemiology - mortality - pathology
Predictive value of tests
Proportional Hazards Models
Retrospective Studies
Sex Distribution
United States - epidemiology
Abstract
Both the European Neuroendocrine Tumor Society (ENETS) and the International Union for Cancer Control/American Joint Cancer Committee/World Health Organization (UICC/AJCC/WHO) have proposed TNM staging systems for pancreatic neuroendocrine neoplasms. This study aims to identify the most accurate and useful TNM system for pancreatic neuroendocrine neoplasms.
The study included 1072 patients who had undergone previous surgery for their cancer and for which at least 2 years of follow-up from 1990 to 2007 was available. Data on 28 variables were collected, and the performance of the two TNM staging systems was compared by Cox regression analysis and multivariable analyses. All statistical tests were two-sided.
Differences in distribution of sex and age were observed for the ENETS TNM staging system. At Cox regression analysis, only the ENETS TNM staging system perfectly allocated patients into four statistically significantly different and equally populated risk groups (with stage I as the reference; stage II hazard ratio [HR] of death = 16.23, 95% confidence interval [CI] = 2.14 to 123, P = .007; stage III HR of death = 51.81, 95% CI = 7.11 to 377, P
PubMed ID
22525418 View in PubMed
Less detail

9 records – page 1 of 1.